CLINICAL-PHARMACOLOGICAL APECTS OF THE USE OF DYDROGESTERONE IN PREGNANCY MAINTENANCE
Акушерство, гинекология и репродукция, 2016 Dydrogesterone is a gestagen with proven pregnancy maintaining efficacy, which has been in common medical practice for more than 15 years in the Russian Federation and for more than 45 years outside of Russia.
E. V. Shikh
doaj
Особенности активационных процессов коры головного мозга при олигоменорее у подростков [PDF]
, 2013 The article presents the data on the epidemiology of menstrual cycle disorders of Krasnoyarsk teenagers. The increase in the frequency of oligomenorrhea, indicating worsening of functional disorders of the reproductive system, has been revealed. Due to
Bragina, Marina A. +3 more
core
Dydrogesterone update: insights on its therapeutic applications [PDF]
Progesterone deficiency is commonly implicated as an important etiology in pregnancy complications like threatened miscarriage, luteal phase defect (LPD), recurrent pregnancy loss (RPL), etc.
Luniya, Sharul Sajjan +2 more
core +2 more sources
Mechanismen immunologischer Toleranz [PDF]
, 2010 Hintergrund Die Schwangerschaft ist ein natürliches, erfolgreiches Modell immunologischer Toleranz [1]. Das Kind, dessen genetisches Material zu 50% allogen ist, wird während der Zeit seiner intrauterinen Entwicklung vom mütterlichen Immunsystem ...
Scholz, Christoph
core
Dydrogesterone use in recurrent pregnancy loss and luteal phase insufficiency: a knowledge, attitude, and practice survey amongst Indian obstetricians and gynaecologists [PDF]
Background: Oral dydrogesterone is effective in treating reproductive disorders such as recurrent pregnancy loss (RPL) and is a better option than progesterone for luteal phase support (LPS) after in-vitro fertilization (IVF).
Bapat, Kawita +16 more
core +2 more sources
Protocol to assess risk of venous thromboembolism associated with use of hormone replacement therapy in real world settings: two nested case-control studies in primary care [PDF]
Hormone replacement therapy (HRT) is used to help women suffering from menopausal symptoms. Although effective, the therapy may have a rare but serious side effect – an increased risk of venous thromboembolism (VTE).
Coupland, Carol +3 more
core
A multicentre phase III study comparing efficacy and safety of novel extended-release versus conventional formulation of dydrogesterone in Indian patients with endometriosis [PDF]
Background: The aim of the study was to compare the efficacy and safety of novel once-daily extended-release (ER) dydrogesterone 20 mg versus conventional twice-daily dydrogesterone 10 mg in Indian patients with endometriosis.
Agarwal, Mukta +9 more
core +2 more sources
Recent trends on dydrogesterone in gynaecology, obstetrics, and infertility: insights from Indian experts [PDF]
Infertility affects millions globally, with significant prevalence in India due to conditions like endometriosis and polycystic ovarian syndrome (PCOS).
Agarwal, Sweta +12 more
core +2 more sources
Analysis of 21 progestagens in various matrices by ultra-high-performance liquid chromatography tandem mass spectrometry (UHPLC-MS/MS) with diverse sample pretreatment [PDF]
, 2014 Chen, Jun +7 more
core +1 more source
Гинекология, 2013 Insulin resistance in patients with obesity leads to indirect menstrual cycle disruption through hyperinsulinemia and hyperleptinemy. In order to correct menstrual disorders, the metabolic characteristics of the optimal progestin should be considered, so
S S Apetov, S Y Kalinchenko
doaj